By Dr. Apurba Kumar Sarma, MCh CVTS | Cardiac Surgeon, Tulip Mediworld Superspeciality Hospital, Guwahati
Quick Takeaways
- Triple vessel disease means all three of the heart’s main coronary arteries are significantly blocked – putting the entire heart muscle at risk, not just one section.
- It is diagnosed through a coronary angiogram or CT Coronary Angiogram, and it is one of the most serious presentations of coronary artery disease (CAD).
- For most patients with triple vessel disease, bypass surgery (CABG) gives significantly better long-term outcomes than stenting – backed by the landmark SYNTAX trial.
- During CABG for triple vessel disease, three bypass routes are created using your own arteries or veins – restoring blood flow to all affected areas of the heart.
- A triple vessel disease diagnosis is frightening, but this condition is exactly what bypass surgery was designed to treat. Many patients go on to live full, active lives after a successful operation.
Receiving a diagnosis of triple vessel disease can feel like the floor has shifted beneath you. Three arteries blocked. The whole heart affected. Words like “bypass” and “surgery” may be entering your vocabulary for the first time – and the uncertainty can feel overwhelming for you and for your family.
I want to begin with something important: triple vessel disease is serious, but it is also one of the most treatable conditions in cardiac surgery. In fact, bypass surgery (CABG) was developed largely in response to exactly this pattern of disease. Over 25 years of performing heart surgery and more than 7,000 successful operations, triple vessel disease has been one of the most common reasons my patients need – and benefit enormously from – coronary artery bypass grafting.
This article will explain what triple vessel coronary artery disease actually means, why bypass surgery is almost always the recommended treatment, and what recovery looks like. If you or someone you love has just received this diagnosis, read on – clarity is the first step toward confidence.
Your heart muscle is supplied by three main coronary arteries:
Coronary artery disease (CAD) develops when fatty deposits (plaques) build up inside these arteries, narrowing them and reducing blood flow to the heart muscle. In single vessel disease, only one artery is significantly affected. In double vessel disease, two. Triple vessel disease – also called three vessel CAD – means all three major arteries have significant narrowings (blockages greater than 70% in most diagnostic definitions).
This matters because the entire heart muscle is now at risk, not just one territory. If a plaque in one artery ruptures and causes a blockage, the resulting heart attack affects a larger area. Symptoms – chest pain or tightness on exertion, breathlessness, fatigue – are often more pronounced and more difficult to control with medication alone.
Triple vessel disease is typically identified through:
Once triple vessel disease is confirmed on angiography, the findings are discussed with a Heart Team – typically a cardiac surgeon and an interventional cardiologist – to decide on the best treatment approach.
This is one of the most important questions patients ask: “Can’t I just have stents? Why do I need open heart surgery?”
It is a fair question. Stenting is a less invasive procedure – a small mesh tube is placed inside the blocked artery to hold it open, without opening the chest. For single and sometimes double vessel disease, stenting can be highly effective.
But for triple vessel disease, the evidence strongly and consistently favours bypass surgery.
The landmark SYNTAX trial – a large randomised trial published in the New England Journal of Medicine comparing CABG and stenting in patients with complex coronary artery disease – showed that patients with triple vessel disease who had bypass surgery had significantly lower rates of major adverse cardiac events (heart attack, repeat procedures, stroke, and death) at both one year and five years compared to those treated with stents. These results have been replicated in long-term follow-up studies, and they form the foundation of current ACC/AHA guidelines for revascularisation, which recommend CABG as the preferred strategy for most patients with triple vessel coronary artery disease.
Why does surgery perform better? Because stents treat individual blockages, but cannot address the underlying disease process throughout the artery. Bypass surgery creates entirely new routes for blood flow – bypassing the diseased sections entirely – and those new routes (especially when the internal mammary artery is used as the graft) remain open and function well for decades.
| Factor | Stenting | Bypass Surgery (CABG) |
|---|---|---|
| Invasiveness | Minimally invasive (catheter) | Open heart surgery (chest opened) |
| Best suited for | Single or double vessel disease, stable anatomy | Triple vessel disease, complex anatomy |
| Treats entire artery territory | Partially | Yes – creates new blood flow routes |
| Long-term outcomes in triple vessel disease | Higher re-intervention rate | Better survival, fewer repeat procedures |
| Recovery time | Days to 1–2 weeks | 6–12 weeks for full recovery |
| Recommended by AHA/ACC guidelines | Limited role in triple vessel CAD | First-line recommendation |
A coronary artery bypass grafting (CABG) procedure for triple vessel disease is sometimes called a “triple bypass” – though this term can be misunderstood. It simply means three bypass grafts are created, one for each blocked coronary artery territory.
During the procedure:
The operation typically takes 3–5 hours. In straightforward cases, patients are in the ICU for 24–48 hours and in hospital for 5–7 days, before beginning a structured recovery programme.
If you are concerned about bypass surgery in Guwahati and what the process involves, our team at Tulip Mediworld can walk you through every step – from admission through to discharge and rehabilitation.
For most patients, the outcomes after successful CABG for triple vessel disease are genuinely encouraging.
Long-term data from the SYNTAX trial and subsequent studies show that patients who undergo successful bypass surgery for triple vessel disease have significantly better survival rates and quality of life compared to those who are managed with medication or stenting alone. Symptoms of chest pain and breathlessness – which can be severe before surgery – typically resolve substantially, because the heart is now receiving the blood supply it needs.
Most patients return to walking and light activity within 4–6 weeks, and to full daily life within 8–12 weeks. Those who follow their cardiac rehabilitation programme, maintain a heart-healthy diet, and take their prescribed medications generally do very well over the long term.
As a CABG surgeon in Assam who has performed this operation hundreds of times across 25 years, I tell patients: the surgery is the hard part – and we carry that weight on your behalf. Your job is the recovery, and with the right support, most people accomplish that more confidently than they expected.
No. A triple vessel disease diagnosis is serious – it means significant blockages in all three major arteries – but it is a treatable condition, and bypass surgery was designed specifically for this presentation. The outcome depends on many factors: the severity of blockages, overall heart function, and whether any heart muscle has already been permanently damaged. Most patients who undergo timely and successful bypass surgery go on to live active, productive lives. The word “serious” should mean “act now and act decisively” – not “give up hope.”
In most cases of true triple vessel disease, especially where the LAD artery is involved and the blockages are complex, the evidence does not favour stenting as the primary treatment. The SYNTAX trial showed clearly higher rates of repeat procedures and major cardiac events in triple vessel disease patients treated with stents compared to those who had bypass surgery. There are occasional exceptions – patients who are too frail for surgery, or whose anatomy is very straightforward – but for the majority, CABG offers meaningfully better long-term outcomes. Your cardiac surgeon and cardiologist will make this assessment together.
Most patients are discharged from hospital within 5–7 days after an uncomplicated triple bypass. The first two weeks at home focus on rest, wound healing, and gentle walking. By 4–6 weeks, most patients can manage daily tasks independently. Full return to work (desk jobs) is typically 6–8 weeks; physical jobs may require 10–12 weeks. Cardiac rehabilitation – a structured programme of supervised exercise, nutritional guidance, and psychological support – significantly improves both the speed and quality of recovery. At Tulip Mediworld, we support patients through each phase of this journey.
Not anymore. Patients across Northeast India – from Assam, Manipur, Meghalaya, Nagaland, Tripura, and Arunachal Pradesh – have been travelling to Delhi, Chennai, or Kolkata for complex cardiac surgery for decades. That is no longer necessary. Tulip Mediworld Superspeciality Hospital in Guwahati has a dedicated Cardiothoracic & Vascular Surgery department, a modern cardiac operation theatre, full ICU facilities, and a team with the experience to handle triple vessel CABG and complex cases. The care you need is here, in your home region.
A diagnosis of triple vessel coronary artery disease is not the end of the conversation. It is the beginning of a treatment plan. And the fact that you are reading this – trying to understand what it means, seeking clarity before making a decision – tells me you are exactly the kind of informed patient who does well.
The key takeaways to carry with you: all three coronary arteries being significantly blocked is serious but treatable. Bypass surgery is the evidence-backed answer for most patients with this diagnosis. And the expertise to perform this surgery safely and successfully is available to you here in Guwahati, without the cost and exhaustion of long-distance travel.
If you have been diagnosed with triple vessel disease, or if you are supporting a family member through this diagnosis, the most valuable next step is a direct conversation with a cardiac surgeon who can review your angiogram results and explain your specific options.
Book a consultation at drapurbasarma.in or call Tulip Mediworld Superspeciality Hospital, Guwahati, on 1800 890 4655. We will take it from here – one step at a time.
About the Author
Dr. Apurba Kumar Sarma, MBBS, MS (General Surgery), MCh (CVTS) is a cardiovascular and thoracic surgeon with over 25 years of experience and 7,000+ successful heart surgeries. He is the Founder, Chairman and Managing Director of Tulip Mediworld Superspeciality Hospital, GS Road, Rukmini Gaon, Guwahati, Assam – 781022. He is a Fellow of the Indian Association of Cardiovascular-Thoracic Surgeons and a Life Member of the Indian Medical Association.
This article is for informational purposes only and does not constitute medical advice. Please consult a qualified cardiac surgeon for evaluation and treatment specific to your condition.
